Hakutulokset - Jean‐François Morère

  • Näytetään 1 - 9 yhteensä 9 tuloksesta
Tarkenna hakua
  1. 1
    Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer

    Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer Tekijä G. Des Guetz, Bernard Uzzan, Jean‐François Morère, G. Perret, Patrick Nicolas

    Julkaistu 2010
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases

    Anti-Programmed Cell Death Protein 1 (PD-1) Immunotherapy for Metastatic Hepatocellular Carcinoma After Liver Transplantation: A Report of Three Cases Tekijä Ouissam Al Jarroudi, Ayhan Ulusakarya, Wathek Almohamad, Saïd Afqir, Jean‐François Morère

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Impact of Physical Activity on Cancer-Specific and Overall Survival of Patients with Colorectal Cancer

    Impact of Physical Activity on Cancer-Specific and Overall Survival of Patients with Colorectal Cancer Tekijä G. Des Guetz, Bernard Uzzan, T. Bouillet, Patrick Nicolas, Kader Chouahnia, Laurent Zelek, Jean‐François Morère

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    P2.15-17 Patient Care in Advanced Lung Cancer: Unmet Needs

    P2.15-17 Patient Care in Advanced Lung Cancer: Unmet Needs Tekijä Jean‐François Morère, François Eisinger, H. Naman, R. Sellami, Christine Lhomel, G. Ganem, Jérôme Viguier, H. Simon

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature

    Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature Tekijä G. Des Guetz, Bernard Uzzan, Patrick Nicolas, Michel Cucherat, Jean‐François Morère, Robert Benamouzig, J.L. Breau, G-Y Perret

    Julkaistu 2006
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype

    IFCT-0401 Trial: A Phase II Study of Gefitinib Administered as First-Line Treatment in Advanced Adenocarcinoma with Bronchioloalveolar Carcinoma Subtype Tekijä J. Cadranel, Élisabeth Quoix, Laurence Baudrin, Pierre Mourlanette, Denis Moro‐Sibilot, Jean‐François Morère, Pierre-Jean Souquet, Jean‐Charles Soria, Franck Morin, B. Milleron

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma

    Upfront association of carboplatin plus pemetrexed in patients with brain metastases of lung adenocarcinoma Tekijä Olivier Bailon, Kader Chouahnia, A. Augier, T. Bouillet, S. Billot, I. Coman, Rénata Ursu, Cathérine Belin, Laurent Zelek, G. Des Guetz, Christine Lévy, Alain Carpentier, Jean‐François Morère

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Impact of EGFR expression on colorectal cancer patient prognosis and survival

    Impact of EGFR expression on colorectal cancer patient prognosis and survival Tekijä Jean‐Philippe Spano, Christine Lagorce, D Atlan, G. Milano, Julien Dômont, Robert Benamouzig, Ahmed Z. Al Attar, Joseph Bénichou, Alejandro Martı́n, Jean‐François Morère, Martine Raphaël, F Penault–Llorca, J.L. Breau, Rémi Fagard, D. Khayat, Philippe Wind

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin

    Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin Tekijä Jean-Louis Pujol, Jean-Luc Breton, R. Gervais, Paul Rebattu, A Depierre, Jean‐François Morère, B. Milleron, D. Debieuvre, D. Castéra, P.-J. Souquet, Denis Moro‐Sibilot, É. Lemarié, Romain Kessler, Henri Janicot, David Braun, D. Spaëth, Xavier Quantin, C. Clary

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: